Abbvie Inc (NYSE:ABBV)

156.02
BATS BZX Real-Time Price
As of 1:10pm ET
 +3.53 / +2.31%
Today’s Change
105.56
Today|||52-Week Range
175.91
+15.23%
Year-to-Date
The Best Stocks to Invest $5,000 in Right Now
11:23am / MotleyFool.com - Paid Partner Content
AbbVie (ABBV) Gains As Market Dips: What You Should Know
Jun 27 / Zacks.com - Paid Partner Content
Is Most-Watched Stock AbbVie Inc. (ABBV) Worth Betting on Now?
9:00am / Zacks.com - Paid Partner Content
Amgen's Big Bet on Copycat Drugs Is Paying Off
Jun 27 / GuruFocus News - Paid Partner Content
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
6:20am / Zacks.com - Paid Partner Content
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Jun 27 / Zacks.com - Paid Partner Content
Investors Need Not Be Alarmed by Drug Patent Expirations
Jun 28 / GuruFocus News - Paid Partner Content
5 Best Dividend Stocks to Buy Now
Jun 27 / MotleyFool.com - Paid Partner Content
2 Buffett Stocks That Outperformed the S&P During the Great Recession
Jun 28 / MotleyFool.com - Paid Partner Content
Is AbbVie About To Get A New Blockbuster Drug?
Jun 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close152.49
Today’s open153.80
Day’s range153.39 - 156.20
Volume2,487,133
Average volume (3 months)7,313,098
Market cap$269.2B
Data as of 1:10pm ET, 06/29/2022

Growth & Valuation

Earnings growth (last year)+137.07%
Earnings growth (this year)+10.42%
Earnings growth (next 5 years)-1.26%
Revenue growth (last year)+22.69%
P/E ratio22.4
Price/Sales4.28
Price/Book17.48

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.39+0.77%
LLYEli Lilly and Co+5.78+1.82%
MRKMerck+0.58+0.63%
AZNAstraZeneca+1.32+2.00%
Data as of 1:10pm ET, 06/29/2022

Financials

Next reporting dateJuly 29, 2022
EPS forecast (this quarter)$3.43
Annual revenue (last year)$56.2B
Annual profit (last year)$11.5B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
North Chicago, Illinois

Forecasts